Announcements Trials
Browse Landscape

Phase

Phase 2 26Phase 3 18Phase 1 11Phase 1/2 3Phase 4 2Phase 2/3 2Phase NA 1Phase EARLY_PHASE1 1

Status

Completed 3Recruiting 2Unknown 1Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Genitourinary 1

Conditions

Neoplasm Metastasis 2Urinary Bladder Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1

Interventions

Cyclophosphamide 142Gemcitabine 129Paclitaxel 125Radiotherapy 119Cisplatin 111Carboplatin 111pembrolizumab 109Nivolumab 106Docetaxel 90Rituximab 86Lenalidomide 77Dexamethasone 76Cytarabine 69Bevacizumab 64Fluorouracil 63Etoposide 63Oxaliplatin 62Filgrastim 59Peripheral Blood Stem Cell Transplantation 58Everolimus 58Capecitabine 58fludarabine phosphate 57Doxorubicin 56Temozolomide 55Prednisone 54Irinotecan 53Cetuximab 50fludarabine 48Ipilimumab 48Erlotinib Hydrochloride 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × Completed × Mitomycin × Clear all
NCT00318643 2021-10-29

Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer

Halozyme Therapeutics

Phase 1/2 Completed
27 enrolled 14 charts
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT02575859 2015-10-15

Adjuvant HIPEC to Prevent Colorectal Peritoneal Metastases in High-risk Patients

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 1/2 Completed
20 enrolled
Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms

NCT00289445 2013-01-28

Study With Mitomycin c/5-FU/FA in Pretreated Gastrointestinal Cancer Patients With Metastases (>= Second-line Treatment)

University Hospital Tuebingen

Phase 1/2 Completed
Gastrointestinal

Gastrointestinal Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡